跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 204 条关于
“NGAL”
全部
204
临床试验
161
药物
32
机构
0
资讯
11
5个月前
BioPorto Divests Antibody Business for $10.5M to Focus on NGAL Biomarker Development
去年
BioPorto Initiates US Study of ProNephro AKI (NGAL) for Adult Acute Kidney Injury Risk Stratification
去年
BioPorto Launches ProNephro AKI Diagnostic Test in US Market Through Roche Partnership
去年
FDA Grants QIDP Status to Venus Remedies' Novel Antibiotic VRP-034 for Bloodstream Infections
2个月前
Cord Blood Biomarkers Show Promise for Early Risk Stratification in Neonatal Encephalopathy, Meta-Analysis Finds
去年
Galimedix Therapeutics Initiates Phase 2 Trial of GAL-101 Eye Drops for Dry AMD
去年
Galimedix Therapeutics Completes Phase 1 Trial of Oral Alzheimer's Drug GAL-101
6个月前
Galimedix Achieves Phase 1 Milestone for Oral GAL-101 in Alzheimer's Disease Development
去年
Galimedix Therapeutics Initiates Phase 1 Trial of Oral GAL-101 for Amyloid Beta Modulation
去年
Galimedix Advances Oral GAL-101 Therapy for Alzheimer's and Eye Diseases in Phase 1 Trial
第 1 页,共 2 页
上一页
下一页